Amy Donahue

4.5k total citations · 1 hit paper
5 papers, 367 citations indexed

About

Amy Donahue is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Amy Donahue has authored 5 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cancer Research, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Oncology. Recurrent topics in Amy Donahue's work include Cancer Genomics and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Amy Donahue is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Pancreatic and Hepatic Oncology Research (1 paper). Amy Donahue collaborates with scholars based in United States. Amy Donahue's co-authors include Mark Kennedy, Priti S. Hegde, Travis Clark, Christine Burns, Pei Ma, Joel Skoletsky, Wei Meng, Jason D. Hughes, Brian M. Alexander and Ninad Dewal and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Amy Donahue

5 papers receiving 362 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin

2020 265 citations Meijuan Li, Jason D. Hughes et al. PLoS ONE profile →

Peers

Countries citing papers authored by Amy Donahue

Since Specialization

Citations

This map shows the geographic impact of Amy Donahue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Donahue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Donahue more than expected).

Fields of papers citing papers by Amy Donahue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Donahue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Donahue. The network helps show where Amy Donahue may publish in the future.

Co-authorship network of co-authors of Amy Donahue

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Donahue. A scholar is included among the top collaborators of Amy Donahue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Donahue. Amy Donahue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

#	Work	Indexed citations
1	Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin breakdown → 2020 ·PLoS ONE ·(unknown), Meijuan Li, Jason D. Hughes, (unknown), Joel Skoletsky, Pei Ma, Wei Meng, Ninad Dewal, Coren A. Milbury, Travis Clark, Amy Donahue, (unknown), Mark Kennedy, (unknown), Christine Burns, Christine Vietz, Brian M. Alexander, Priti S. Hegde, Lucas Dennis	265
2	Abstract 4699: Analytical validation of solid tumor fusion gene detection in a comprehensive NGS-based clinical cancer genomic test 2014 ·Cancer Research ·Roman Yelensky, Amy Donahue, Geoff Otto, Michelle Nahas, Jie He, Frank Juhn, Sean R. Downing, Garrett M. Frampton, Juliann Chmielecki, Jeffrey S. Ross, Maureen F. Zakowski, Marc Ladanyi, Vincent A. Miller, Philip J. Stephens, Doron Lipson	1
3	Clinical next‐generation sequencing successfully applied to fine‐needle aspirations of pulmonary and pancreatic neoplasms 2013 ·Cancer Cytopathology ·Geneva Young, Kai Wang, Jie He, Geoff Otto, Matthew Hawryluk, (unknown), Tina Brennan, Michelle Nahas, Amy Donahue, Roman Yelensky, Doron Lipson, Christine E. Sheehan, Ann Boguniewicz, Philip J. Stephens, Vincent A. Miller, Jeffrey S. Ross	98
4	Patient Derived Xenograft (PDX) Models Faithfully Recapitulate The Genetic Composition Of Primary AML 2013 ·Blood ·Andrei V. Krivtsov, Xujun Wang, Noushin Farnoud, Michael Hadler, Kristina M. Knapp, Eytan M. Stein, Martin S. Tallman, Amy Donahue, Doron Lipson, Michelle Nahas, Philip J. Stephens, Eric M. Sanford, Kai Wang, Garrett M. Frampton, Timothy J. Brennan, Geoff Otto, Roman Yelensky, Vincent A. Miller, Ross L. Levine, Scott A. Armstrong	1
5	Use of next-generation sequencing (NGS) to detect a novel ALK fusion and a high frequency of other actionable alterations in colorectal cancer (CRC). 2012 ·Journal of Clinical Oncology ·Jeffrey S. Ross, Doron Lipson, Christine E. Sheehan, Geoff Otto, Roman Yelensky, Alex Parker, Mirna Jarosz, Frank Juhn, Tina Brennan, Sean R. Downing, Amy Donahue, Sohail Balasubramanian, Gary A. Palmer, Vincent A. Miller, Philip Stephens, Maureen Cronin	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact